Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Audit MicroControls has updated its logo, mission statement, and social media campaign. Audit’s mission is to supply daily QC and calibration verification/linearity materials to clinical labs worldwide while providing support, real-time data-reduction tools, same-day shipping, and quality products at a fair price.
ViroStat offers two new sets of Monotope monoclonal antibodies to the major capsid protein of the GI and GII noroviruses. The new antibodies function in ELISA and lateral flow applications for rapid detection of these viruses.
Quest Diagnostics and Hologic have entered into a strategic alliance to more broadly offer testing based on Hologic’s Aptima family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women’s health.
The FDA has approved a workflow process for Roche Diagnostics’ Cobas HPV test that allows sample processing from the primary sample collection vial after it has been used for cytology (Pap) testing. Labs can load the same vial used for a ThinPrep Pap test directly onto the Cobas 4800 system for high-risk HPV and individual HPV 16 and 18 genotype testing. The workflow option uses a special primary vial rack for the Cobas 4800. The Cobas HPV test, approved by
Biocare Medical’s Supernova antibodies contain a higher antibody concentration than standard predilutes. Clients now have the option of preserving limited tissue specimens while still providing multi-antigen identification in about the same time as an antibody cocktail. This is achieved using Supernova antibodies in sequential incubations combined with Biocare’s double stain detection. Unique cocktails can also be created with ease as Supernova antibodies have been prepared in optimal diluents for specific tissue types. Supernova antibodies require between 10- and 20-minute incubations.
Kreatech has signed an agreement with the Lung Cancer Mutation Consortium (LCMC) allowing LCMC study sites to use Kreatech’s Repeat-Free Poseidon fluorescent in situ hybridization (FISH) probes to help identify molecular (DNA) changes in study samples.
Saladax Biomedical has been certified as a registered CLIA laboratory by the Office of Clinical Standards and Quality, a part of CMS that regulates lab testing performed on humans. The CLIA certification and approval allows the company to begin clinical laboratory operations for its MyCare product portfolio at facilities in Bethlehem, Pa.
Siemens Healthcare Diagnostics has obtained FDA clearance to offer pleural fluid pH testing on its RapidPoint 500 blood gas system. The addition of pleural fluid pH testing to the RapidPoint 500 complements the analyzer’s critical care menu, which includes blood gas, electrolyte, glucose, lactate, and full CO-oximetry tests, including neonatal total bilirubin and total hemoglobin.
BG Medicine’s galectin-3 testing has been recognized in the 2013 American College of Cardiology Foundation and American Heart Association (ACCF/AHA) Guideline for the Management of Heart Failure, which is designed to assist clinicians in selecting the best management strategy for patients and provides analysis of prevention, diagnosis, risk stratification, and treatment data.
Thermo Fisher Scientific’s Orbitrap Fusion Tribrid liquid chromatography-mass spectrometry (LC-MS) system combines its quadrupole, Orbitrap, and linear ion trap mass analyzers in a “Tribrid” architecture that analyzes complex biological samples.
